Bronchial Asthma & COVID-19

Asthma & COVID-19
14 August 2020

Bronchial Asthma is a commonly occurring condition in individuals of all age groups. A typical bronchial asthmatic individual has a swollen and narrow airway. The degree of severity varies from person-to-person, and may change over a period of time.

COVID-19 and Bronchial Asthma have a number of common symptoms such as coughing, sneezing, wheezing, shortness of breath and chest pain. However, the primary and most prominent symptom of the coronavirus is a low to high-grade fever. Bronchial Asthma can be caused by both hereditary (inherited) and environmental factors; whereas, the COVID-19 is said to spread primarily through close contact from person-to-person. The severity of Bronchial Asthma
varies seasonally, while COVID-19 is a newly identified life threatening virus. Like any other person, a bronchial asthmatic can contract the coronavirus. If the patient has damaged lungs, it may lead to Chronic Obstructive Lung Disease (COPD).

Bronchial Asthma can be treated with relievers and preventer inhalers; however, there is no established treatment for COVID-19. For managing both conditions, it is important to continue medication and practice preventive strategies to avoid new attacks and infections.